Harnessing novel T cell systems to extend the promise of immunotherapy.

Biotechnology

TScan Therapeutics

TScan Therapeutics' headquarters in Waltham, MA, United States

Gavin MacBeath

Ray Lockard

Cagan G.

Sarah Bertino

Jim Murray

Chrystal U Louis

Justin McCue

Jason A. Amello

Zoran Zdraveski

Ann Hargraves

Tomasz Kula

Kai Wucherpfennig

Malcolm Brenner

Stephen Biggar

Timothy Barberich

Stephen Elledge

Katina Dorton

Gabriela Gruia

Barbara Klencke

The Research and Development Scientists at TScan Therapeutics are focused on advancing novel T cell therapies for immunotherapy applications. This multidisciplinary team conducts cutting-edge research, develops new technologies and products, and executes preclinical studies to enhance the efficacy of cancer treatments. They collaborate on various projects, ranging from therapeutic discovery to process development, ensuring a seamless transition from laboratory research to clinical application.

Research and Development Scientists

The Research and Development team at TScan Therapeutics is focused on pioneering innovative T cell therapies by leveraging cutting-edge scientific research and translational techniques. This team collaborates to design and optimize novel immunotherapeutic strategies, overseeing the entire process from discovery through to clinical development, ensuring effective translation of laboratory findings into viable treatments for patients.

Research and Development

The Leadership Team at TScan Therapeutics is responsible for setting the strategic direction and overall vision of the company. They oversee critical functions including research and development, clinical operations, investor relations, and regulatory compliance, ensuring that novel T cell therapies are effectively brought from the lab to clinical application. This collaborative team fosters a culture of innovation while driving operational excellence and stakeholder engagement to advance the field of immunotherapy.

Leadership Team

The Regulatory Affairs and Compliance team at TScan Therapeutics is responsible for ensuring that the company's innovative T cell therapies meet all regulatory requirements and quality standards. This team navigates the regulatory landscape to facilitate the approval process for new therapies, while also overseeing compliance with operational protocols and quality assurance practices to maintain the integrity and safety of immunotherapeutic products.

Regulatory Affairs and Compliance

The Finance and Operations team at TScan Therapeutics is responsible for ensuring the financial health and operational efficiency of the company. They oversee financial reporting, budgeting, and analysis, while also managing technical accounting matters. This team collaborates closely with other departments to optimize resource allocation and support the company's mission of advancing innovative T cell therapies in immunotherapy.

Finance and Operations

The Human Resources Function at TScan Therapeutics is dedicated to cultivating a high-performing and inclusive workforce that supports the company's mission in immunotherapy. This team manages talent acquisition, employee engagement, compensation, and benefits, ensuring that the organization attracts and retains top talent while fostering a positive and collaborative workplace culture.

TScan Therapeutics

Org chart

Board & advisors

Teams

Research and Development Scientists

Research and Development

Leadership Team

Regulatory Affairs and Compliance

Finance and Operations

Human Resources Function

Offices

TScan Therapeutics

Org chart

Board & advisors

Teams

Research and Development Scientists

Research and Development

Leadership Team

Regulatory Affairs and Compliance

Finance and Operations

Human Resources Function

Offices

Related companies